0409-2336 : Deferoxamine Mesylate 500 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 0409-2336
Labeler: Hospira, Inc.
Product Type: Human Prescription Drug
Drug Name:  Deferoxamine Mesylate
Dosage Form: Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: ANDA076019
Rev. Date: 


NDC Package Codes:

  • 0409-2336-10: 4 VIAL, SINGLE‑USE IN 1 CARTON (0409‑2336‑10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE
  • 0409-2336-13: 10 VIAL, SINGLE‑USE IN 1 CARTON (0409‑2336‑13) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Deferoxamine Mesylate

Dosage Strength:

  • 500 mg

Pharmaceutical Classes:

  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]

Related Products:

Based on records with the same trade name.
  • 0409-2337 Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0555-1131 Deferoxamine Mesylate 2 g/20ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Barr Laboratories Inc.
  • 0555-1132 Deferoxamine Mesylate 500 mg/5ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Barr Laboratories Inc.
  • 47781-623 Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
  • 47781-624 Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
  • 52609-4504 Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Apopharma USA, Inc.
  • 52609-4505 Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apopharma USA, Inc.
  • 60505-6236 Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
  • 60505-6237 Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
  • 60505-6238 Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
  • 68083-172 Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
  • 68083-173 Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0409-2336 QR Code

< Prev: 0409-2312Next: 0409-2337 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.